DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03714334 |
|
Recruitment Status :
Terminated
(Break of stock)
First Posted : October 22, 2018
Last Update Posted : April 7, 2023
|
Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Collaborator:
DNAtrix, Inc.
Information provided by (Responsible Party):
Clinica Universidad de Navarra, Universidad de Navarra
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | April 5, 2023 |
| Actual Study Completion Date : | April 5, 2023 |